Literature DB >> 23576562

Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells.

Luis E Arias-Romero1, Olga Villamar-Cruz, Min Huang, Klaus P Hoeflich, Jonathan Chernoff.   

Abstract

p21-Activated kinase-1 (Pak1) is frequently upregulated in human breast cancer and is required for transformation of mammary epithelial cells by ErbB2. Here, we show that loss of Pak1, but not the closely related Pak2, leads to diminished expression of β-catenin and its target genes. In MMTV-ErbB2 transgenic mice, loss of Pak1 prolonged survival, and mammary tissues of such mice showed loss of β-catenin. Expression of a β-catenin mutant bearing a phospho-mimetic mutation at Ser 675, a specific Pak1 phosphorylation site, restored transformation to ErbB2-positive, Pak1-deficient mammary epithelial cells. Mice bearing xenografts of ErbB2-positive breast cancer cells showed tumor regression when treated with small-molecule inhibitors of Pak or β-catenin, and combined inhibition by both agents was synergistic. These data delineate a signaling pathway from ErbB2 to Pak to β-catenin that is required for efficient transformation of mammary epithelial cells, and suggest new therapeutic strategies in ErbB2-positive breast cancer. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23576562      PMCID: PMC3687032          DOI: 10.1158/0008-5472.CAN-12-4453

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

Review 1.  The genetics of Pak.

Authors:  Clemens Hofmann; Mikhail Shepelev; Jonathan Chernoff
Journal:  J Cell Sci       Date:  2004-09-01       Impact factor: 5.285

2.  Genetic deletion of Rac1 GTPase reveals its critical role in actin stress fiber formation and focal adhesion complex assembly.

Authors:  Fukun Guo; Marcella Debidda; Linda Yang; David A Williams; Yi Zheng
Journal:  J Biol Chem       Date:  2006-05-11       Impact factor: 5.157

3.  Specificity profiling of Pak kinases allows identification of novel phosphorylation sites.

Authors:  Ulrike E E Rennefahrt; Sean W Deacon; Sirlester A Parker; Karthik Devarajan; Alexander Beeser; Jonathan Chernoff; Stefan Knapp; Benjamin E Turk; Jeffrey R Peterson
Journal:  J Biol Chem       Date:  2007-03-28       Impact factor: 5.157

Review 4.  Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity.

Authors:  Suresh K Rayala; Poonam R Molli; Rakesh Kumar
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.

Authors:  Ke Wang; Qingyong Ma; Yu Ren; Jianjun He; Yong Zhang; Yunfeng Zhang; Wuke Chen
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

6.  Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts.

Authors:  Y Tang; Z Chen; D Ambrose; J Liu; J B Gibbs; J Chernoff; J Field
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  Nuclear localization and chromatin targets of p21-activated kinase 1.

Authors:  Rajesh R Singh; Chunying Song; Zhibo Yang; Rakesh Kumar
Journal:  J Biol Chem       Date:  2005-03-03       Impact factor: 5.157

8.  The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338.

Authors:  A J King; H Sun; B Diaz; D Barnard; W Miao; S Bagrodia; M S Marshall
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

9.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.

Authors:  W J Muller; E Sinn; P K Pattengale; R Wallace; P Leder
Journal:  Cell       Date:  1988-07-01       Impact factor: 41.582

10.  Localization of p21-activated kinase 1 (PAK1) to pinocytic vesicles and cortical actin structures in stimulated cells.

Authors:  S Dharmawardhane; L C Sanders; S S Martin; R H Daniels; G M Bokoch
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

View more
  38 in total

1.  Molecular pathways: targeting the kinase effectors of RHO-family GTPases.

Authors:  Tatiana Y Prudnikova; Sonali J Rawat; Jonathan Chernoff
Journal:  Clin Cancer Res       Date:  2014-10-21       Impact factor: 12.531

Review 2.  Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration.

Authors:  Jessie Wettig Yester; Bernhard Kühn
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

3.  HER2 and β-catenin protein location: importance in the prognosis of breast cancer patients and their correlation when breast cancer cells suffer stressful situations.

Authors:  F Darío Cuello-Carrión; Jorge E Shortrede; Daiana Alvarez-Olmedo; Niubys Cayado-Gutiérrez; Gisela N Castro; Felipe C M Zoppino; Martín Guerrero; Estefania Martinis; Rodolfo Wuilloud; Nidia N Gómez; Verónica Biaggio; Javier Orozco; Francisco E Gago; Leonardo A Ciocca; Mariel A Fanelli; Daniel R Ciocca
Journal:  Clin Exp Metastasis       Date:  2015-02-01       Impact factor: 5.150

Review 4.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

5.  p21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 Pathway.

Authors:  Maria Radu; Karen Lyle; Klaus P Hoeflich; Olga Villamar-Cruz; Hartmut Koeppen; Jonathan Chernoff
Journal:  Mol Cell Biol       Date:  2015-09-21       Impact factor: 4.272

Review 6.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

7.  P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.

Authors:  Ahmad Al-Azayzih; Fei Gao; Payaningal R Somanath
Journal:  Biochim Biophys Acta       Date:  2015-03-06

Review 8.  Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases.

Authors:  Rakesh Kumar; Aswathy Mary Paul; Ravikumar Amjesh; Bijesh George; M Radhakrishna Pillai
Journal:  Cancer Metastasis Rev       Date:  2020-08-21       Impact factor: 9.264

9.  Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways.

Authors:  X Cai-McRae; H Zhong; V Karantza
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

10.  FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.

Authors:  Silvia Licciulli; Jasna Maksimoska; Chun Zhou; Scott Troutman; Smitha Kota; Qin Liu; Sergio Duron; David Campbell; Jonathan Chernoff; Jeffrey Field; Ronen Marmorstein; Joseph L Kissil
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.